Technical Analysis for MNOV - MediciNova, Inc.

Grade Last Price % Change Price Change
grade F 8.62 -0.92% -0.08
MNOV closed down 0.92 percent on Monday, March 18, 2019, on 28 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MNOV trend table...

Date Alert Name Type % Chg
Mar 18 Fell Below 20 DMA Bearish 0.00%
Mar 18 Bollinger Band Squeeze Range Contraction 0.00%
Mar 18 Narrow Range Bar Range Contraction 0.00%
Mar 18 NR7 Range Contraction 0.00%
Mar 18 BB Squeeze Started Range Contraction 0.00%
Mar 18 Inside Day Range Contraction 0.00%
Mar 15 Crossed Above 20 DMA Bullish -0.92%
Mar 15 Pocket Pivot Bullish Swing Setup -0.92%
Mar 14 Fell Below 20 DMA Bearish 1.53%
Mar 14 Spinning Top Other 1.53%

Older signals for MNOV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a ß2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.
Medicine Health Pain Medication Multiple Sclerosis Asthma Respiratory Therapy Serious Diseases Central Nervous System Disorders Pulmonology Solid Tumor Cancers Urinary Incontinence Interstitial Cystitis
Is MNOV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.01
52 Week Low 6.68
Average Volume 52,629
200-Day Moving Average 9.5582
50-Day Moving Average 8.8268
20-Day Moving Average 8.69
10-Day Moving Average 8.531
Average True Range 0.3806
ADX 8.0
+DI 29.2095
-DI 27.1106
Chandelier Exit (Long, 3 ATRs ) 8.6082
Chandelier Exit (Short, 3 ATRs ) 7.8218
Upper Bollinger Band 9.3155
Lower Bollinger Band 8.0645
Percent B (%b) 0.44
BandWidth 14.395857
MACD Line -0.0229
MACD Signal Line -0.0351
MACD Histogram 0.0122
Fundamentals Value
Market Cap 302.29 Million
Num Shares 35.1 Million
EPS -0.29
Price-to-Earnings (P/E) Ratio -29.72
Price-to-Sales 0.00
Price-to-Book 6.66
PEG Ratio -0.91
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.85
Resistance 3 (R3) 8.85 8.79 8.81
Resistance 2 (R2) 8.79 8.73 8.78 8.79
Resistance 1 (R1) 8.70 8.69 8.67 8.70 8.78
Pivot Point 8.64 8.64 8.62 8.63 8.64
Support 1 (S1) 8.55 8.58 8.52 8.55 8.46
Support 2 (S2) 8.49 8.54 8.48 8.45
Support 3 (S3) 8.40 8.49 8.43
Support 4 (S4) 8.40